Sardini A, Mintenig G M, Valverde M A, Sepúlveda F V, Gill D R, Hyde S C, Higgins C F, McNaughton P A
Department of Physiology, King's College London, UK.
J Cell Sci. 1994 Dec;107 ( Pt 12):3281-90. doi: 10.1242/jcs.107.12.3281.
P-glycoprotein (P-gp), the product of the human multidrug resistance (MDR1) gene, confers multidrug resistance on cells by acting as an ATP-dependent drug transporter. A method using confocal microscopy was developed to measure the transport activity of P-gp from the rate of movement of doxorubicin, a fluorescent substrate of P-gp, across the membrane of a single cell. Recent work has shown that expression of P-gp enhances the activation of chloride channels in response to cell swelling, suggesting that membrane stretch might switch P-gp from a drug-transporting mode to a mode in which it activates chloride channels. In agreement with this idea, we find that cell swelling inhibits drug efflux in cells expressing P-gp but is without effect on the slower background efflux in cells not expressing P-gp and in cells transiently transfected with a mutated MDR1 in which the ATP hydrolysis sites had been inactivated. The identification of a novel means for inhibiting P-gp-mediated drug transport may have implications for the reversal of multidrug resistance during chemotherapy.
P-糖蛋白(P-gp)是人类多药耐药(MDR1)基因的产物,作为一种依赖ATP的药物转运体,赋予细胞多药耐药性。人们开发了一种利用共聚焦显微镜的方法,通过P-gp的荧光底物阿霉素跨单细胞膜的移动速率来测量P-gp的转运活性。最近的研究表明,P-gp的表达会增强细胞肿胀时氯离子通道的激活,这表明膜拉伸可能会使P-gp从药物转运模式转变为激活氯离子通道的模式。与这一观点一致,我们发现细胞肿胀会抑制表达P-gp的细胞中的药物外排,但对不表达P-gp的细胞以及用ATP水解位点已失活的突变MDR1瞬时转染的细胞中较慢的背景外排没有影响。鉴定一种抑制P-gp介导的药物转运的新方法可能对化疗期间多药耐药的逆转具有重要意义。